The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

NBIX FINANCIAL STATEMENTS

Neurocrine Biosciences Inc — balance sheet, income statement and cash flow trends

NBIXNeurocrine Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B2 B3 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.4 B $Gross Profit3.3 B $ · 98%Operating Income788.9 M $ · 23%Pre-tax Income940.2 M $ · 28%Net Income to Owners705.5 M $ · 21%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.4 B $+34.4%
Gross Profit3.3 B $+33.7%
Operating Income788.9 M $+59.4%
EBITDA918.1 M $+60.8%
Net Income to Owners705.5 M $+102.6%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets5.4 B
  • Equity3.7 B $69%
  • Current Liabilities874.5 M $16%
  • Long-term Liabilities791 M $15%

Key Figures

YoY change
Total Assets5.4 B $+37.8%
Total Liabilities1.7 B $+39.3%
Total Equity3.7 B $+37.1%
Cash & ST Investments389.8 M $-60.0%
Total Debt401.8 M $-8.5%
Net Debt69.4 M $-60.4%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0250 M500 M750 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0250 M500 M750 M898.1 M $Operating-891.2 M $Investing60.2 M $Financing67.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow898.1 M $+58.3%
Capital Expenditures32.5 M $-15.8%
Free Cash Flow870.4 M $+64.6%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on NBIX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.